PROSPECT provides clinicians with supporting arguments for and against the use of various interventions in postoperative pain based on published evidence and expert opinion. Clinicians must make judgments based upon the clinical circumstances and local regulations. At all times, local prescribing information for the drugs referred to must be consulted.
Open thoracotomy remains a common procedure despite the growing use of video-assisted thoracoscopic surgery and is considered one of the most painful surgical interventions (Gonzalez 2021; Mehta 2023). Severe postoperative pain not only impacts immediate recovery but is associated with postoperative pulmonary complications (Makkad 2023). Additionally, inadequate postoperative pain control increases the risk of chronic post-thoracotomy pain (Makkad 2023). Therefore, timely and effective analgesia is essential to optimize postoperative rehabilitation and reduce long-term morbidity.
This review (Lemoine 2026) aimed to assess the current literature and update previous PROSPECT recommendations for optimal pain management after open thoracotomy. The first PROSPECT recommendations on pain management after open thoracotomy were available online in 2004 (subsequently published: Joshi 2008) and updated online in 2015 (Thoracotomy 2015 summary recommendations).
The current systematic review and formulation of the recommendations were performed using the unique PROSPECT methodology, available at https://esraeurope.org/prospect-methodology/. This methodology was first published in Joshi 2019 and updated in Joshi 2023. Literature databases (Embase, Medline, PubMed, and Cochrane) were searched from January 2015 to April 2024 to identify randomised controlled trials, systematic reviews, and meta-analyses (in English) that investigated pharmacological, non-pharmacological, or surgical interventions and assessed postoperative pain scores. 100 studies met the inclusion criteria. PROSPECT recommendations were based on interpretation of the evidence, considering the current clinical relevance of the studied interventions and their risk/benefit profile, use of baseline pain treatment, and the procedure-specific context.
This review is registered on PROSPERO: CRD42022309453.
COX, cyclo-oxygenase; NSAID, non-steroidal anti-inflammatory drug.
Analgesic interventions that are not recommended for pain management in patients undergoing open thoracotomy.
PROSPECT recommendations for open thoracotomy – Infographic
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.